Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
2009 ◽
Vol 101
(7)
◽
pp. 1044-1050
◽
P N Munster
◽
D Marchion
◽
S Thomas
◽
M Egorin
◽
S Minton
◽
...
2013 ◽
Vol 108
(5)
◽
pp. 1061-1070
◽
M A Warso
◽
J M Richards
◽
D Mehta
◽
K Christov
◽
C Schaeffer
◽
...
2011 ◽
Vol 106
(1)
◽
pp. 77-84
◽
R Pili
◽
B Salumbides
◽
M Zhao
◽
S Altiok
◽
D Qian
◽
...
Rebecca S. Kristeleit
◽
Richard D. Baird
◽
Balaji Venugopal
◽
Duncan K. Wilkins
◽
Fiona MacCormick
◽
...
2005 ◽
Vol 23
(16_suppl)
◽
pp. 2108-2108
◽
A. Lopez-Martin
◽
R. Cubedo
◽
I. Garcia-Rivas
◽
D. Castellano
◽
A. Perez-Romero
◽
...
2012 ◽
Vol 107
(8)
◽
pp. 1277-1285
◽
M F Kozloff
◽
L P Martin
◽
M Krzakowski
◽
T A Samuel
◽
T A Rado
◽
...
2010 ◽
Vol 8
(7)
◽
pp. 130-131
A.P. Moore
◽
S. Thomas
◽
C.J. Ryan
◽
T.M. Jahan
◽
S.G. DuBois
◽
...
2004 ◽
Vol 40
(14)
◽
pp. 2047-2052
◽
Ulrich Keilholz
◽
Ronny Schuster
◽
Alexander Schmittel
◽
Nikolaos Bechrakis
◽
Jan Siehl
◽
...
2002 ◽
Vol 38
◽
pp. S55-S56
2010 ◽
Vol 101
(1)
◽
pp. 196-200
◽
Takashi Watanabe
◽
Harumi Kato
◽
Yukio Kobayashi
◽
Satoshi Yamasaki
◽
Yuriko Morita-Hoshi
◽
...
F. Pein
◽
F. Doz
◽
D. Frappaz
◽
E. Lucchi
◽
S. Moretti
◽
...